These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 2187599)
1. Activation of c-Ki-ras in human gastrointestinal dysplasias determined by direct sequencing of polymerase chain reaction products. Meltzer SJ; Mane SM; Wood PK; Resau JH; Newkirk C; Terzakis JA; Korelitz BI; Weinstein WM; Needleman SW Cancer Res; 1990 Jun; 50(12):3627-30. PubMed ID: 2187599 [TBL] [Abstract][Full Text] [Related]
2. K-ras point mutations are rare events in premalignant forms of Barrett's oesophagus. Trautmann B; Wittekind C; Strobel D; Meixner H; Keymling J; Gossner L; Ell C; Hahn EG Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):799-804. PubMed ID: 8864678 [TBL] [Abstract][Full Text] [Related]
3. Detection of c-ras gene mutation and expression of p21 protein in dysplasias and carcinomas complicating ulcerative colitis. Tsuda T; Mochizuki M; Wakasa H J Gastroenterol; 1995 Nov; 30 Suppl 8():30-2. PubMed ID: 8563883 [TBL] [Abstract][Full Text] [Related]
4. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus. Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048 [TBL] [Abstract][Full Text] [Related]
5. Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis. Lang SM; Heinzlmann M; Stratakis DF; Teschauer W; Loeschke K Am J Gastroenterol; 1997 Dec; 92(12):2166-70. PubMed ID: 9399746 [TBL] [Abstract][Full Text] [Related]
6. Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers. Nagata Y; Abe M; Kobayashi K; Yoshida K; Ishibashi T; Naoe T; Nakayama E; Shiku H Cancer Res; 1990 Feb; 50(3):480-2. PubMed ID: 2404571 [TBL] [Abstract][Full Text] [Related]
7. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572 [TBL] [Abstract][Full Text] [Related]
8. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine. Wang Y; You M; Reynolds SH; Stoner GD; Anderson MW Cancer Res; 1990 Mar; 50(5):1591-5. PubMed ID: 2406014 [TBL] [Abstract][Full Text] [Related]
9. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis. Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584 [TBL] [Abstract][Full Text] [Related]
10. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Suzuki Y; Orita M; Shiraishi M; Hayashi K; Sekiya T Oncogene; 1990 Jul; 5(7):1037-43. PubMed ID: 2197591 [TBL] [Abstract][Full Text] [Related]
11. Differential activation of the c-Ki-ras-2 proto-oncogene in human colorectal carcinoma. Halatsch ME; Hirsch-Ernst KI; Weinel RJ; Kahl GF Anticancer Res; 1998; 18(4A):2323-5. PubMed ID: 9703874 [TBL] [Abstract][Full Text] [Related]
12. Associations between dietary intake and Ki-ras mutations in colon tumors: a population-based study. Slattery ML; Curtin K; Anderson K; Ma KN; Edwards S; Leppert M; Potter J; Schaffer D; Samowitz WS Cancer Res; 2000 Dec; 60(24):6935-41. PubMed ID: 11156393 [TBL] [Abstract][Full Text] [Related]
13. Microsatellite instability and K-ras mutations in patients with ulcerative colitis. Lyda MH; Noffsinger A; Belli J; Fenoglio-Preiser CM Hum Pathol; 2000 Jun; 31(6):665-71. PubMed ID: 10872658 [TBL] [Abstract][Full Text] [Related]
14. Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride. Froment O; Boivin S; Barbin A; Bancel B; Trepo C; Marion MJ Cancer Res; 1994 Oct; 54(20):5340-5. PubMed ID: 7923162 [TBL] [Abstract][Full Text] [Related]
15. Mutations of the Ki-ras oncogene in carcinoma of the endometrium. Caduff RF; Johnston CM; Frank TS Am J Pathol; 1995 Jan; 146(1):182-8. PubMed ID: 7856726 [TBL] [Abstract][Full Text] [Related]
16. Activation of RAS family genes in urothelial carcinoma. Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097 [TBL] [Abstract][Full Text] [Related]
17. Mutation of ras oncogene in gastric adenocarcinoma: association with histological phenotype. Kim TY; Bang YJ; Kim WS; Kang SH; Lee KU; Choe KJ; Kim NK Anticancer Res; 1997; 17(2B):1335-9. PubMed ID: 9137494 [TBL] [Abstract][Full Text] [Related]
18. p53 in esophageal adenocarcinoma: a critical reassessment of mutation frequency and identification of 72Arg as the dominant allele. Chung SM; Kao J; Hyjek E; Chen YT Int J Oncol; 2007 Dec; 31(6):1351-5. PubMed ID: 17982662 [TBL] [Abstract][Full Text] [Related]
19. Frequency and spectrum of c-Ki-ras mutations in human sporadic colon carcinoma, carcinomas arising in ulcerative colitis, and pancreatic adenocarcinoma. Burmer GC; Rabinovitch PS; Loeb LA Environ Health Perspect; 1991 Jun; 93():27-31. PubMed ID: 1773797 [TBL] [Abstract][Full Text] [Related]
20. Early mutational activation of the c-Ki-ras oncogene in endometrial carcinoma. Duggan BD; Felix JC; Muderspach LI; Tsao JL; Shibata DK Cancer Res; 1994 Mar; 54(6):1604-7. PubMed ID: 8137266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]